Call for Abstracts is CLOSED!

Notification of ABSTRACT DISPOSITION: August 2019



Registration Requirements

Accepted authors are expected to pay their own travel expenses and conference registration fee(s). Dates of presentation cannot be guaranteed.


Late Breaking Abstract Submission will open August 12, 2019.

Late Breaking abstracts are considered for Poster Presentation ONLY.


Abstracts are invited for consideration for the Tissue Engineering and Regenerative Medicine International Society - Americas (TERMIS-AM) 2019 Conference and Exposition, December 2- 5, 2019 at the Loew’s Sapphire Falls Hotel in Orlando, FL.  The TERMIS-AM 2019 Conference will feature an outstanding scientific program bringing together national and international communities of scientists, clinicians, industry leaders, post-doctoral fellows, graduate students, entrepreneurs, and representatives of government funding agencies engaged in the fields of tissue engineering and regenerative medicine.

Abstract Consideration

Experts from academia, industry and government are invited to present timely research to successful implementation of technologies in all areas of tissue engineering/regenerative medicine.

Please submit your abstracts to one of the categories, which will then filter into the session titles upon the review of abstracts. If your abstract does not fit within any of these areas, please list your abstract in the "other" category. Please note sessions are slotted based on the amount of abstracts submitted.


  • Applications and Challenges for Dental Pulp Stem Cells Use in Tissue Engineering
  • ASMB Guest Symposium: The Extracellular Matrix in Morphogenesis and Repair
  • Biobased Materials for Regenerative Medicine
  • Biomaterials for Central Nervous System Diseases and Regeneration with Focus on Imaging and Bio-Inspired Strategies
  • Educational Aspects in Tissue Engineering and Regenerative Medicine
  • Engineering implants for the treatment of endocrine/metabolic diseases
  • Immunomodulatory Strategies in Tissue Engineering and Regenerative Medicine
  • In Situ Regeneration of Complex Tissues by Recruitment of Endogenous Stem Cells
  • In Vitro and Translational Studies in Neural and Spine Engineering
  • Information Technology, Computational Modeling and Simulations and Automation for Biofabrication
  • Laryngotracheal Repair and Regeneration
  • Metallic Biomaterials for Regenerative Medicine
  • Musculoskeletal Tissue Engineering and Regenerative Medicine Approaches
  • New Approaches in Dental & Craniofacial Repair and Regeneration
  • New Approaches to Cardiovascular Repair and Regeneration
  • Regenerative Medicine in Ophthalmology
  • Respiratory, Urologic and Gastrointestinal Engineering
  • Scaffolds, Matrices, and Biomaterials
  • Skin, Wound Healing, and Inflammation
  • Stem Cell-Based Articular Cartilage Engineering
  • Stem Cells & Cell Therapies & Developmental Biology and Cell Signaling
  • Strategies for Tissue Microvascularization
  • Tools for Imaging and Assessment of Engineered Tissues and Biomaterials
  • Translating Microphysiological Systems Technology to Preclinical Drug Development and Disease Modeling
  • Translating TERM to the Market
  • Traversing Biomaterial and Cellular Strategies to Restore Tissue Stretch

Abstract Preparation

Authors must submit their abstract electronically.



Once logged into the OASIS portal, you will see the submission steps on the right-hand side. These can be completed out of order, but the system will not accept any abstract if a step is incomplete.

Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font and mixed case font followed by a single return. Do not put a period at the end of the title. Example: This is a Properly Formatted Abstract Title

Category: Please select the TWIG category that your abstract falls under.

Authors: This is where you will enter your authors and it will be separate from your abstract body. Please enter information in the fields provided and the system with format it for you automatically. Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting the abstract file. 

Disclosure Information goes in this same step under each individual speaker. In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the subject. Examples include, but are not limited to:

  • Stock options or bond holdings in a for-profit corporation or self-directed pension plan
  • Employment (full or part-time)
  • Ownership or partnership
  • Consulting fees or other remuneration (payment)
  • Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
  • Receipt of royalties
  • Speakers bureau

Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.

Note: Presenting authors are expected to pay their own travel expenses and conference registration fee(s).

Keyword(s): Please enter a minimum of one keyword and a maximum of 5 keywords.

Abstract: The abstract should clearly describe the nature of the research and the problem it addresses and be presented in such language as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize the purpose/objective of the research, the methodology employed, the results, and the conclusion/significance and will be split into these four categories.


  • The abstract length is limited to 500 words total across all four sections. These areas should not include authors, disclosures, or references.
  • Please no figures or tables in the abstract.
  • References and acknowledgements are not needed in this abstract process.

Presentation Preference: Please choose your preferred method of presentation (Oral, Poster, or Oral or Poster) where indicated. Your preference will be noted by the reviewers. Final determination will be made by the Scientific Advisory Committee.

Publication: All abstracts will be published in Tissue Engineering, Part A. All authors agree to the submission and the publication of the abstract, if accepted. You can opt-out of having your abstract published in this step. 

Demographics: You can select if you are a Student or Young Investigator here.

You will then have an opportunity to review and edit your work before submitting the abstract.

You may revise your abstract no later than 11:59 pm Pacific Time on Wednesday, June 5, 2019, by returning to the site and logging in again. After the deadline, all completed abstracts in the system will be sent to the Abstract Reviewers for review. Any abstracts left "incomplete" will not be sent for review. There are no exceptions.



If the abstract must be withdrawn, the TERMIS-AM office must be notified in writing at least ONE month prior to the meeting via e-mail to Tatiana Veres at





For more information on abstract content, format and submission procedure, contact:

Tatiana Veres
Meeting Coordinator